How do I install the Es Rtcgm Adip Vs Mdis Smbg T1d skill?

Run npx skillmds@latest add dromlakhani/es-rtcgm-adip-vs-mdis-smbg-t1d in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Es Rtcgm Adip Vs Mdis Smbg T1d safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: makes network calls. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Es Rtcgm Adip Vs Mdis Smbg T1d?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Es Rtcgm Adip Vs Mdis Smbg T1d free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Es Rtcgm Adip Vs Mdis Smbg T1d?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Es Rtcgm Adip Vs Mdis Smbg T1d by dromlakhani

Name: Es Rtcgm Adip Vs Mdis Smbg T1d
Rating: 4.5 (4 reviews)
Author: dromlakhani

Es Rtcgm Adip Vs Mdis Smbg T1d

This skill suggests using real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D). Trigger phrases include "Should I use RT-CGM+ADIP or MDI+SMBG for this T1D patient?" or "Is intensive pump therapy indicated for this patient?"

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

RT-CGM+ADIPs vs MDIs+SMBG for Type 1 Diabetes

STEP 1 — Gather Information

Confirm T1D diagnosis, current MDI+SMBG regimen (≥3 checks/day), age, hypoglycemia history, impaired awareness, patient tech readiness, and insurance/device access.

STEP 2 — Rule In / Rule Out

Is the patient with T1D using MDI with SMBG three or more times daily? If yes, proceed; if no, consider alternative glucose monitoring/insulin strategies.

STEP 3 — Classify or Stratify

Stratify by hypoglycemia risk: high (prior severe episodes or impaired awareness) vs lower risk. High-risk patients benefit most; lower-risk patients still considered based on preference and access.

STEP 4 — Decide

For qualifying patients, prescribe RT-CGM+ADIP with structured education; retain SMBG for calibration/confirmation; schedule follow‑up to assess TIR, hypoglycemia, and device tolerance.

Clinical Guardrails / Mimics / Pitfalls

Do not rely solely on CGM without confirmatory SMBG; avoid in patients unable to respond to alerts or manage device wear; do not overlook cost/coverage barriers; never skip diabetes education on device use and hypoglycemia prevention.

Concrete Clinical Example

A 12‑year‑old with T1D on MDI+SMBG 4×/day reports nocturnal hypoglycemia and impaired awareness. After confirming eligibility, RT‑CGM+ADIP is started with training; SMBG used twice daily for calibration. At 3‑month review, TIR improves from 55% to 70% and severe hypoglycemia events drop from 2/month to 0.

Source: Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2023, https://doi.org/10.1210/clinem/dgac596

---name: es-rtcgm-adip-vs-mdis-smbg-t1ddescription: This skill suggests using real-time continuous glucose monitoring (CGM) and algorithm-driven insulin pumps (ADIPs) rather than multiple daily injections (MDIs) with self-monitoring of blood glucose (SMBG) three or more times daily for adults and children with type 1 diabetes (T1D). Trigger phrases include "Should I use RT-CGM+ADIP or MDI+SMBG for this T1D patient?" or "Is intensive pump therapy indicated for this patient?"---# RT-CGM+ADIPs vs MDIs+SMBG for Type 1 Diabetes## STEP 1 — Gather InformationConfirm T1D diagnosis, current MDI+SMBG regimen (≥3 checks/day), age, hypoglycemia history, impaired awareness, patient tech readiness, and insurance/device access.## STEP 2 — Rule In / Rule OutIs the patient with T1D using MDI with SMBG three or more times daily? If yes, proceed; if no, consider alternative glucose monitoring/insulin strategies.## STEP 3 — Classify or StratifyStratify by hypoglycemia risk: high (prior severe episodes or impaired awareness) vs lower risk. High-risk patients benefit most; lower-risk patients still considered based on preference and access.## STEP 4 — DecideFor qualifying patients, prescribe RT-CGM+ADIP with structured education; retain SMBG for calibration/confirmation; schedule follow‑up to assess TIR, hypoglycemia, and device tolerance.## Clinical Guardrails / Mimics / PitfallsDo not rely solely on CGM without confirmatory SMBG; avoid in patients unable to respond to alerts or manage device wear; do not overlook cost/coverage barriers; never skip diabetes education on device use and hypoglycemia prevention.## Concrete Clinical ExampleA 12‑year‑old with T1D on MDI+SMBG 4×/day reports nocturnal hypoglycemia and impaired awareness. After confirming eligibility, RT‑CGM+ADIP is started with training; SMBG used twice daily for calibration. At 3‑month review, TIR improves from 55% to 70% and severe hypoglycemia events drop from 2/month to 0.**Source:** Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2023, https://doi.org/10.1210/clinem/dgac596

Frequently asked questions